Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by MJgroweron Jan 20, 2017 9:56am

88 Views

Post# 25733198

VP Taking it on the chin

Hey Luka, Orbital, Patricky and others, go bash on the VP sight if you want cheap shares...if you take away VP's reverse split then the SP is currently at 7 cents pre-split, I wonder how that Cautious guys is doing over there as he was bashing NF pretty hard not long ago LOL

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading